Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Cellect Biotechnology Ltd (APOP)

6.91 0.005 (0.07%)

05-25 16:00

Open:

6.87

Pre. Close:

6.905

High:

7

Low:

6.87

Volume:

3,257

Market Cap:

45M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.006 - 7.055

7.055 - 7.094

Low:

6.777 - 6.83

6.83 - 6.871

Close:

6.842 - 6.923

6.923 - 6.985

Technical analysis  (as of: 2018-05-25 4:32:12 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 12.61     One year: 15.79

Support:

Support1: 6.40    Support2: 5.32

Resistance:

Resistance1: 10.80    Resistance2: 13.52

Pivot:

7.37

Moving Averages:

MA(5): 6.97     MA(20): 7.19

MA(100): 7.51     MA(250): 7.71

MACD:

MACD(12,26): 0.15     Signal(12,26,9): 0.21

%K %D:

%K(14,3): 4.64     %D(3): 5.87

RSI:

RSI(14): 48.47

52-Week:

High: 13.5  Low: 6.12  Change(%): -25.1

Average Vol(K):

3-Month: 2136  10-Days 1471

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
APOP has closed above bottom band by 42.9%. Bollinger Bands are 275.2% wider than normal. The large width of the bands suggest high volatility as compared to APOP's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-05-25T10:49:52-04:00
Magenta Therapeutics on deck for IPO

2018-05-17T16:59:00-04:00
Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results

2018-05-10T07:00:00-04:00
Former GE Healthcare Executive to Join Cellect as Chief Business Officer

2018-04-09T07:59:34-04:00
Cellect Bio up 21% premarket on advancement of new stem cell production technique

2018-04-09T07:00:00-04:00
Cellect Announces a Major Milestone for Enabling Stem Cells Production

2018-03-19T16:25:23-04:00
Cellect Biotechnology reports Q4 results

2018-03-19T16:15:00-04:00
Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

2018-02-01T12:00:00-05:00
Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

6.51

Shares Float (M)

6.51

% Held by Insiders

% Held by Institutions

Shares Short (K)

94

Shares Short Prior Month (K)

119

Stock Financials

EPS

-0.820

EPS Est. Current Year

-1.560

EPS Est. Next Year

-1.350

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

8.480

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-92.7

Return on Equity (ttm)

-126.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.749

Qtrly Earnings Growth

Operating Cash Flow (M)

-5.03

Levered Free Cash Flow (M)

-2.57

atoplab.com

Valuation

P/E

-8.43

P/E Growth Ratio

P/BV

0.81

P/S

P/CF

-8.94

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.